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GENETIC POLYMORPHISMS IN THE GENES ENCODING HUMAN INTER-
LEUKIN RECEPTOR 7A (IL-7RA): PROGNOSTIC SIGNIFICANCE IN AL-
LOGENEIC STEM CELL TRANSPLANTATION (SCT)
Shamim, Z.; Ryder, L.P.; Heilmann, C.; Madsen, H.O.; Svejgaard, A.;
Jacobsen, N.; Muller, K. Rigshospitalet National University Hospital,
Copenhagen, Denmark.
Interleukin-7 (IL-7) belongs to the haematopoietic family of
cytokines, being essential for T cell development in the thymus and
maintenance of peripheral T cells. IL-7 signals through IL-7R,
which consists of a gamma common chain and an alpha-chain. The
alpha-chain is also used by the receptor of thymic stromal lympho-
poitin (TSLP), a cytokine with complex effects on cytokine proﬁles
including induction of TNF production by dendritic cells. Se-
quencing of IL-7R-alpha has revealed the existence of 4 single
nucleotide polymorphisms (SNPs): (510C/T, 1237 A/G,
2087T/C and 3110A/G), which all give rise to amino acid sub-
stitutions. The aim of the present investigation was to evaluate the
signiﬁcance of IL-7R-alpha SNPs for the outcome and for treat-
ment related complications in allogeneic SCT. Patients and
Methods: IL-7R-alpha polymorphisms were determined in
genomic DNA from 200 recipient and donor pairs from either
matched sibling donors or matched unrelated donors (MUD) by an
SSP-PCR system. Transplants with mismatch family donors or
mismatch unrelated donors were excluded. Genotyping of 173
normal controls was performed in parallel. The indication for SCT
included ALL (n 51), CML (n 51), AML (n 51), MDS (n
12), and various nonmalignant disorders (n35). Results: In
MUD transplants, the1237 genotype of the donor was associated
with the survival after SCT, the mortality being highest and inter-
mediate for the GG and AG genotypes, respectively (P  .043).
This pattern was more pronounced with respect to treatment
related mortality (P  .0042), while IL-7R-alpha genotypes were
unrelated to the risk of relapse of leukaemia. In line with this, the
occurrence of GvHD at day 100 was related to the 1237
genotype of the donor (GG [43%], AG [13%], and AA [3%]; P 
.0055). The IL-7R-alpha1237 genotypes of the recipient and the
genotypes of the other 3 polymorphisms were not signiﬁcantly
associated with the outcome of SCT. Conclusion: The presented
data suggest that the IL-7 pathway may be of pathogenetic impor-
tance for transplant related mortality after SCT. The 1237 poly-
morphism is located at the extracellular part of IL-7R-alpha, and
may inﬂuence binding or signalling through IL-7R. Furthermore,
this study suggests that selection of donors based on IL-7R-alpha
typing, in addition to HLA-typing, may help to reduce treatment
related mortality in SCT.
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MESENCHYMAL STEM CELLS INDUCE DIVISION ARREST ANERGY OF
ACTIVATED T CELLS
Glennie, S.J.1; Soeiro, I.2; Dyson, J.1; Lam, E.2; Dazzi, F.1 1. Depart-
ment of Immunology-Hammersmith Hospital, London, United King-
dom; 2. Imperial Cancer Research Fund, London, United Kingdom.
It has been demonstrated that bone marrow mesenchymal stem
cells (MSC) inhibit T cell responses both to polyclonal stimuli and
their cognate antigen. We analyzed the effect of MSC on T cell
activation, effector function and proliferation using an in vitro
murine model in which T cells were generated against the male
HY minor histocompatibility antigen. T cell proliferation and
intracellular IFN- staining were used to measure T cell responses.
In the presence of MSC, early activation markers CD25 and CD69
were found to be up regulated on stimulated T cells, whereas
IFN- production was inhibited. To determine the effect of MSC
on T cell proliferation, CFSE-labeled HY-speciﬁc T cells were
stimulated with class I-restricted HY peptides. In the presence of
MSC the intensity of CFSE-stained T cells remained unchanged
demonstrating that T cell proliferation was completely abrogated.
Analysis of the cell cycle showed that T cells, stimulated in the
presence of MSC, were arrested at the G1 phase. At the molecular
level cyclinD2 expression was profoundly inhibited, whereas
p27kip1 was upregulated. When MSC were removed from the
cultures and restimulated with the cognate peptide, T cells pro-
duced IFN- but failed to proliferate. The addition of exogenous
interleukin-2 did not restore proliferation. MSC did not preferen-
tially target any T cell subset, and the inhibition was also extended
to B cells. MSCmediated inhibition induces an unresponsive T cell
proﬁle that is fully consistent with that observed in division arrest
anergy. Our data have important implications on the clinical use of
MSC for tolerance induction.
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IN VIVO FUNCTIONAL IMAGING OF HEMATOPOIETIC STEM CELL EN-
GRAFTMENT
Stein, J.1; Askenasy, N.1; Farkas, D.2; Yaniv, I.1 1. Frankel Laboratory
of Experimental Bone Marrow Transplantation, Schneider Children’s
Medical Center of Israel, Petach Tikva, Israel; 2. Department of Sur-
gery, Cedars Sinai Medical Center, Los Angeles, CA.
Durable hematopoietic stem cell (HSC) engraftment requires
efﬁcient homing to and seeding in the recipient bone marrow
(BM). Dissection of cellular and molecular mechanisms by retro-
spective analysis of functional engraftment studies imposes severe
limitations on the understanding of the early stages of this process.
We have established a new experimental approach for in vivo
functional imaging of PKH-labeled cells at the level of recipient
BM microenvironment, in real time. An optical window is placed
over the distal femur of mice, and labeled cells injected into a
peripheral vein are tracked by ﬂuorescence microscopy. The phys-
iological competence of the procedure was assessed in a series of
control experiments. (a) Blood supply is not compromised and BM
infrastructure is not damaged, as determined from histology and
viability tests. (b) Labeling with PKH dyes does not impair the
function of HSC. (c) PKH-labeled cells were tracked for 3 weeks in
the host femoral BM through the optical window (n 36). (d) The
number of HSC visualized through the optical window at magni-
ﬁcations of  10–20 can be quantiﬁed. (e) In vivo observations
were validated by optical analysis of naive femurs 1, 3, 6, and 12
days after injection of PKH-labeled HSC, and by durable, multi-
lineage hematopoietic chimerism at 4 months. The behavior of
HSC in windowed and naive femurs was qualitatively and quanti-
tatively identical. The major limitations of the procedure are (a)
time-consuming technique; (b) the ﬁeld of view is obliterated by
callus formation after 3 weeks; (c) photobleaching of the PKH dyes
and dilution due to cell division; (d) in vivo observations need to be
continuously validated by analysis of naive femurs to determine the
impact of bone repair on the BM microenvironment. In vivo
optical imaging is particularly suitable to study the mechanisms of
early HSC engraftment, quantify gene delivery in HSC, and mon-
itor graft-versus-host reactions in the BM.
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